Stock Research: Medicover

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Medicover

OM:MCOV B SE0009778848
24
  • Value
    10
  • Growth
    100
  • Safety
    Safety
    19
  • Combined
    24
  • Sentiment
    25
  • 360° View
    360° View
    24
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers healthcare services (primary care, specialist outpatient and inpatient care via clinics and medical facilities) and diagnostic services (laboratory testing for humans and some veterinary services). The company primarily operates in Poland, Germany, Romania, and Ukraine. In the last fiscal year, the company had a market cap of $4085 million, profits of $464 million, revenue of $2166 million, and 47256 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 24 (better than 24% compared with alternatives), overall professional sentiment and financial characteristics for the stock Medicover are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Medicover. The consolidated Growth Rank has a good rank of 100, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 100% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 19 means that the share price of Medicover is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 81% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 10, which means that the company has a riskier financing structure than 90% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 25, indicating professional investors are more pessimistic about the stock than for 75% of alternative investment opportunities. ...read more

more
Index
Human Rights
SDG 13
SDG 16
SDG 3
SDG 4
SDG 8
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 16-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
19 34 28 29
Growth
100 98 100 87
Safety
Safety
10 9 14 42
Sentiment
25 42 42 41
360° View
360° View
24 39 41 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
51 51 41 43
Opinions Change
26 50 83 50
Pro Holdings
n/a 24 4 30
Market Pulse
64 49 59 56
Sentiment
25 42 42 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
19 34 28 29
Growth
100 98 100 87
Safety Safety
10 9 14 42
Combined
24 34 41 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
12 17 10 13
Price vs. Earnings (P/E)
75 75 73 64
Price vs. Book (P/B)
7 16 22 18
Dividend Yield
39 45 47 48
Value
19 34 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
90 85 94 84
Profit Growth
100 88 71 96
Capital Growth
86 68 93 6
Stock Returns
83 90 57 97
Growth
100 98 100 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
4 5 16 46
Refinancing
19 16 15 37
Liquidity
23 24 24 30
Safety Safety
10 9 14 42

Similar Stocks

Discover high‑ranked alternatives to Medicover and broaden your portfolio horizons.

Continental

XTRA:CON
Country: Germany
Industry: Auto Parts & Equipment
Size: X-Large
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Repsol

BME:REP
Country: Spain
Industry: Oil & Gas Integrated
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.